Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure

Aim: It has been reported that angiotensin converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin–angiotensin–aldosterone system. However, angiotensin converting enzyme (ACE)/ACE2 balance in the development of human heart failure is not well established. Methods: Here we evaluate...

Full description

Bibliographic Details
Main Authors: Jiang Wang, Nan Li, Feng Gao, Rong Song, Shanjun Zhu, Zhaohua Geng
Format: Article
Language:English
Published: SAGE Publications 2015-09-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320315576257
_version_ 1797288997589876736
author Jiang Wang
Nan Li
Feng Gao
Rong Song
Shanjun Zhu
Zhaohua Geng
author_facet Jiang Wang
Nan Li
Feng Gao
Rong Song
Shanjun Zhu
Zhaohua Geng
author_sort Jiang Wang
collection DOAJ
description Aim: It has been reported that angiotensin converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin–angiotensin–aldosterone system. However, angiotensin converting enzyme (ACE)/ACE2 balance in the development of human heart failure is not well established. Methods: Here we evaluated the expression of ACE and ACE2 at the mRNA and protein levels in the myocardium of 78 patients with mild or moderate to severe heart failure and in 13 cases with normal myocardium. Results: In the myocardium of patients with dilated or ischemic cardiomyopathy, ACE and ACE2 expression at the mRNA and protein levels was significantly increased compared with those in normal myocardium ( P <0.01, P <0.01, respectively). The ratios of ACE/ACE2 mRNA and ACE/ACE2 were lower in the myocardium of patients with mild heart failure than those in normal myocardium but higher than those in patients with moderate to severe heart failure. Conclusions: ACE and ACE2 expression at the mRNA and protein levels are significantly increased in the myocardium of patients with heart failure. The compensatory mechanism of patients with mild heart may cause the decreased ACE/ACE2 ratio. However, increased ACE/ACE2 ratios may induce angiotensin II over-activation and accelerate cardiac remodeling in patients with moderate to severe heart failure.
first_indexed 2024-03-07T18:57:43Z
format Article
id doaj.art-cc7e6edcd7524beda33bed8ccb257af9
institution Directory Open Access Journal
issn 1470-3203
1752-8976
language English
last_indexed 2024-03-07T18:57:43Z
publishDate 2015-09-01
publisher SAGE Publications
record_format Article
series Journal of the Renin-Angiotensin-Aldosterone System
spelling doaj.art-cc7e6edcd7524beda33bed8ccb257af92024-03-02T00:08:16ZengSAGE PublicationsJournal of the Renin-Angiotensin-Aldosterone System1470-32031752-89762015-09-011610.1177/1470320315576257Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failureJiang WangNan LiFeng GaoRong SongShanjun ZhuZhaohua GengAim: It has been reported that angiotensin converting enzyme 2 (ACE2) is an endogenous counter-regulator of the renin–angiotensin–aldosterone system. However, angiotensin converting enzyme (ACE)/ACE2 balance in the development of human heart failure is not well established. Methods: Here we evaluated the expression of ACE and ACE2 at the mRNA and protein levels in the myocardium of 78 patients with mild or moderate to severe heart failure and in 13 cases with normal myocardium. Results: In the myocardium of patients with dilated or ischemic cardiomyopathy, ACE and ACE2 expression at the mRNA and protein levels was significantly increased compared with those in normal myocardium ( P <0.01, P <0.01, respectively). The ratios of ACE/ACE2 mRNA and ACE/ACE2 were lower in the myocardium of patients with mild heart failure than those in normal myocardium but higher than those in patients with moderate to severe heart failure. Conclusions: ACE and ACE2 expression at the mRNA and protein levels are significantly increased in the myocardium of patients with heart failure. The compensatory mechanism of patients with mild heart may cause the decreased ACE/ACE2 ratio. However, increased ACE/ACE2 ratios may induce angiotensin II over-activation and accelerate cardiac remodeling in patients with moderate to severe heart failure.https://doi.org/10.1177/1470320315576257
spellingShingle Jiang Wang
Nan Li
Feng Gao
Rong Song
Shanjun Zhu
Zhaohua Geng
Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
Journal of the Renin-Angiotensin-Aldosterone System
title Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
title_full Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
title_fullStr Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
title_full_unstemmed Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
title_short Balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
title_sort balance between angiotensin converting enzyme and angiotensin converting enzyme 2 in patients with chronic heart failure
url https://doi.org/10.1177/1470320315576257
work_keys_str_mv AT jiangwang balancebetweenangiotensinconvertingenzymeandangiotensinconvertingenzyme2inpatientswithchronicheartfailure
AT nanli balancebetweenangiotensinconvertingenzymeandangiotensinconvertingenzyme2inpatientswithchronicheartfailure
AT fenggao balancebetweenangiotensinconvertingenzymeandangiotensinconvertingenzyme2inpatientswithchronicheartfailure
AT rongsong balancebetweenangiotensinconvertingenzymeandangiotensinconvertingenzyme2inpatientswithchronicheartfailure
AT shanjunzhu balancebetweenangiotensinconvertingenzymeandangiotensinconvertingenzyme2inpatientswithchronicheartfailure
AT zhaohuageng balancebetweenangiotensinconvertingenzymeandangiotensinconvertingenzyme2inpatientswithchronicheartfailure